Galson Steven K - Insider Non-Derivative Transactions at BIOCRYST PHARMACEUTICALS INC (BCRX) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Jun 12, 2024, Galson Steven K's relationship to BIOCRYST PHARMACEUTICALS INC (BCRX) is Director, and currently has 36,431 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other BCRX insiders.

Data Source: SEC.
Galson Steven K - Insider Non-Derivative Transactions of BCRX Common Stock
Galson Steven K - Insider Non-Derivative Transactions at BCRX
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Jun 13, 2024 Acquisition -- (Common Stock) 6820 0 36431
May 14, 2024 P -- (Common Stock) 21940 5.49 51551
Jun 14, 2023 Acquisition -- (Common Stock) 16745 0 29611